Objective: The most common surgical procedure for obesity is liposuction, the majority of which are small-volume procedures. The effect of large-volume liposuction on cardiovascular risk and insulin sensitivity has been variable. This study was performed to evaluate the effect of the more common, smaller-volume liposuction on insulin sensitivity, inflammatory mediators, and cardiovascular risk factors. Subjects and study design: In all, 15 overweight or obese premenopausal women underwent metabolic evaluation prior to, 1 day following and 1 month following suction lipectomy of the abdomen. Metabolic evaluation included assessment of free fatty acids, glucose, insulin, insulin sensitivity by frequently sampled i.v. glucose tolerance test, and adipokines (IL-6, angiotensin II, leptin, PAI-1, adiponectin, and TNF-a). Results: Free fatty acids did not change acutely although there was an almost 30% decrease in free fatty acids at 1 month. Fasting insulin levels decreased at one month from 8.371.1 to 5.671.3 mU/ml (P ¼ 0.006). Insulin sensitivity by i.v. glucose tolerance test did not change at 1 month (4.070.8 to 5.070.7, P ¼ 0.12) although with subgroup analysis insulin sensitivity improved in obese but not overweight participants. Several adipokines worsened acutely (IL-6 increased 15 fold and angiotensin II increased 67%), but there was no change in PAI-1, and other adipokines (adiponectin, leptin, and TNF-a) decreased. At the 1-month follow-up, all adipokines were similar to baseline. Conclusion: This study provides little evidence supporting increased or decreased cardiovascular risk although there is evidence supporting improved insulin sensitivity at one month, especially in obese women.
Introduction
Obesity is the second leading cause of preventable death in the United States, and data from the recent National Health and Nutrition Examination Survey (NHANES) reveal that over 30% of adults are obese (BMI430 kg/m 2 ). 1 Although conclusive data regarding the effect of weight loss on mortality are not available, data from the Diabetes Prevention Program 2 and the Finnish Diabetes Prevention Study 3 show that modest weight loss (5-7%) with lifestyle intervention significantly decreases the progression to diabetes in high-risk groups. In addition to the risk of diabetes, obesity is a major modifiable risk factor for cardiovascular disease. 4 This is due in part to several interacting factors between obesity and cardiovascular disease including dyslipidemia, hypertension, and abnormal hemostasis. Numerous adipose tissue derived hormones (or adipokines) might alter cardiovascular risk through changes in insulin action, hypertension, and vascular inflammatory status including leptin, TNFa, adiponectin, and interleukin-6 (IL-6), angiotensin II, free fatty acids, and PAI-1.
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Suction lipectomy is the most common cosmetic surgical procedure performed in the United States with over 200 000 procedures in 1998. 6 The vast number of potential candidates, the relative ease of performance, the safety, and the high patient satisfaction rate with suction lipectomy are the primary reasons for its popularity. Suction lipectomy is performed by a variety of physicians including plastic surgeons, dermatologists, and otolaryngologists. Given that the procedure is traditionally performed for cosmetic reasons, there are no specific recommendations with respect to appropriate degree of obesity for the procedure, and suction lipectomy is often performed on individuals with a BMI in the normal or overweight categories. Prior to the liposuction, there is an infusion of buffered saline, and in general suction lipectomy is divided into large volume and small volume based on the volume of infusion (45 l or o5 l respectively). The safety is greater in with the smallervolume liposuction using multiple separate procedures, and smaller-volume liposuction is the more common procedure.
As adipose tissue is a complex organ that both regionally and systemically affects metabolism, there is reason to consider the effect of its removal by lipectomy on metabolism. Traditionally, the visceral adipose tissue depot that is not impacted by suction lipectomy, has been thought to be the most metabolically active. Insulin sensitivity is highly negatively correlated with the amount of visceral adipose tissue. 7 However, abdominal subcutaneous adipose tissue might also play a significant metabolic role. 8 Subcutaneous adipose tissue can be divided into a superficial layer with a compact fascia (Camper's fascia), and a deep layer of less organized fascia (Scarpa's fascia). 9 The deeper subcutaneous adipose tissue has also been shown to be metabolically active. Insulin sensitivity has been shown to be negatively correlated with the amount of deep subcutaneous adipose tissue equal to the negative correlation between insulin sensitivity and visceral adipose tissue. 9 Up to 50% of the subcutaneous adipose tissue is in the deep compartment, and this tissue is removed with liposuction.
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Acute and more long-term alterations in adipose tissue factors such as TNF-a, adiponectin, and leptin would be expected to alter long-term insulin sensitivity 5, 11, 12 and consistent with this hypothesis, several studies have shown improved insulin sensitivity (either fasting glucose and insulin values or insulin tolerance test) 1-6 months following large-volume suction lipectomy. 13 Additionally, changes in the adipocyte derived factors PAI-1, IL-6, leptin, and angiotensin II might alter short-term or longer-term cardiovascular risk. [14] [15] [16] One large-volume lipectomy study has demonstrated that 6 months following the procedure there was a significant decrease in IL-6, TNF-a and CRP, whereas there was a significant increase in adiponectin. 17 However, another recent study found no effect of largevolume liposuction on either insulin sensitivity (measured by staged hyperinsulinemic euglycemic clamp) or inflammatory mediators (adiponectin, TNF-a, IL-6, and C-reactive protein). 18 It has been proposed that the failure of adipogenesis and lack of appropriate storage for lipid might be a major etiology in insulin resistance and type 2 diabetes, 19 and thus the resultant 'lipid overflow'
following the loss of large amounts of adipose tissue with liposuction could explain the lack of improvement of insulin sensitivity.
As the few studies that have examined the effects of suction lipectomy on obesity-related complications have evaluated the effect with large-volume lipectomy, 13, 17, 18, 20, 21 we undertook this study in order to assess the effect of smallvolume suction lipectomy of the abdomen on adipokines, insulin sensitivity, and cardiovascular risk. Both the acute (1 day) and longer-term (1 month) effects of suction lipectomy on adipokines and insulin sensitivity were evaluated. Additionally, the effect of abdominal suction lipectomy on insulin sensitivity in overweight compared to obese individuals was evaluated. The hypothesis proposed was that there would be an initial worsening of insulin sensitivity and increase in adipokines, but that there would be an improvement in these factors at 1 month.
Methods
A total of 15 overweight and obese (BMI 25-35 kg/m 2 ) premenopausal women (age 23-45 years) were enrolled. All subjects were at their maximum body weight and weight stable for at least 3 months. All subjects had fasting glucose values o100 mg/dl. Subjects were recruited from the University of Iowa campus and gave written informed consent prior to beginning the study. The University of Iowa Institutional Review Board approved the study.
Women were studied during the follicular phase of their menstrual cycle. Subjects underwent body composition measurement by dual-energy X-ray absorptiometry using the model DPX whole-body scanner (Lunar Radiation Corp., Madison, WI). Total truncal fat was determined from the DEXA data following exclusion of arm and leg regions of interest. Height was measured with a wall-mounted stadiometer and weight measured in a hospital gown on an analog scale. Prior to studies, subjects were instructed to follow weight maintenance diet consisting of 30% of total calories from fat, 50% from carbohydrate, and 20% from protein. Subjects were also asked to refrain from exercise during the 3 days prior to the study.
For the initial study days, the participants were asked to come to the University of Iowa General Clinical Research Center the evening prior to the study. They were fed a snack at approximately 8 pm, and then remained fasted until the completion of the suction lipectomy the following day. The following morning, baseline blood was drawn and subjects then underwent a test of insulin sensitivity using the insulin modified frequently sampled i.v. glucose tolerance test (FSIVGTT). 22 Insulin and glucose values were entered into the MINMOD program (R Bergman, University of Southern California) for determination of insulin sensitivity (S I ), acute insulin response to glucose (AIRg), and glucose effectiveness (Sg). The AIRg measures endogenous insulin production in response to a glucose load, Sg estimates the efficiency of glucose removal independent of the effect of insulin, and S I measures the sensitivity of tissues to the effect of insulin. The homeostasis model assessment of insulin sensitivity (HOMA) was calculated using fasting plasma glucose (in mmol/l) multiplied by fasting insulin (in mU/ml) divided by 25. 23 The revised quantitative insulin sensitivity check index (QUICKI)
Small-volume liposuction and metabolism DA Davis et al was calculated as the reciprocal of the sum of the logarithm of glucose (in mg/dl) plus the logarithm of insulin (in mU/ml) plus the logarithm of free fatty acids (in mmol/l). 24 Suction lipectomy of the abdomen was then performed. 25 Preoperative sedation with 1-2 mg lorazapam and 0.1 mg clonidine was administered to all participants (one participant did not receive clonidine but was included as there were no differences in metabolic data). The abdomen was marked and preoperatively photographed. Subjects remained comfortable, alert, oriented, and interactive throughout tumescent suction lipectomy. Infiltration of tumescent local anesthesia was performed with clean technique. A volume of 2.5-4.7 l of a bicarbonate buffered saline solution including lidocaine (final dose 50.471.4 mg/kg) and epinephrine (1 ml of 1:1000 epinephrine/l) was infused. Approximately 2 l (18807213 ml, range 1000-3700 ml) of adipose aspirate supernatant were harvested with 1-3 mm cannulas, as required for given treatment sites. Participants were bandaged and compression garment placed. Following lipectomy, the subject's fast was broken and they were fed a snack. At 30 min, a post-lipectomy blood draw was obtained. Subjects were then fed dinner (macronutrient composition as in the baseline phase) at approximately 1800 and stayed overnight on the GCRC. The following morning, a repeat fasting blood draw was performed and participants underwent another FSIVGTT and were discharged home with no specific diet or activity recommendations.
Approximately 1 month following lipectomy, a DEXA and measurement of waist circumference were performed. With calories adjusted for their current weight, each subject repeated the 3-day weight-maintaining macronutrient diet and were asked to refrain from exercise.
The participants were admitted to the GCRC the evening prior to their 1-month follow-up. They were fed dinner (40% of total daily calories, macronutrient composition as in the baseline phase) at approximately 1800 and remained fasted until the completion of the study the following day. The following morning, baseline blood was drawn and an FSIVGTT was performed.
Assays
Glucose was measured using hexokinase methodology (Roche Diagnostic Systems, Indianapolis IN), whereas triglycerides and free fatty acids were measured using enzymatic colorimetric assays (Roche Diagnostic Systems, Indianapolis IN and Wako Chemicals, Richmond VA, respectively). Adiponectin and leptin were assayed with radioimmunoassay (RIA) (Linco Research, St Charles, MO). Angiotensin II was also assayed using RIA (ALPCO Diagnostics, Windham NH). Insulin was measured using a double antibody RIA (DPC, Los Angles CA). IL-6 and TNF-a were measured using an enzymatic immunoassay (R&D Systems, Minneapolis, MN), and PAI-1 was measured using an enzymatic immunoassay (American Diagnostica, Stamford, CT).
Data analysis
The change in body composition, adipokines, and insulin action parameters 24 h and 1 month after suction lipectomy were tested using repeated-measures analysis with time (pretreatment, immediate post-, 24 h post-, and 1-month post-treatment) as the within subject repeated-measures factor. Post-hoc tests involved pairwise comparison of the response variables at each of the post-treatment time points with those at pretreatment were made using two-tailed paired t-test or Wilcoxon signed rank test when data were not normally distributed. An adjusted P-value of o0.05 was considered as statistically significant.
Results
All participants tolerated the procedure well without adverse events. There was no acute change in anthropomorphic measures around the time of the liposuction, however, 1 month following the procedure the participants had an average of 2% weight loss with a significant decrease in total fat and an almost 4% decrease in truncal fat by DEXA ( Table 1) .
The measures related to insulin sensitivity are presented in Table 2 . Free fatty acids did not change around the time of the liposuction, however, there was an almost 30% decrease in free fatty acids at the 1-month follow-up. There was also a significant decrease in fasting insulin levels at the 1-month Small-volume liposuction and metabolism DA Davis et al follow-up from 8.371.1 to 5.671.3 mU/ml (P ¼ 0.006). As a result of these changes, there was a significant increase in estimates of insulin sensitivity including the revised QUICKI and HOMA. The FSIVGTT, a more robust measure of insulin sensitivity, failed to show a significant change in insulin sensitivity at the 1-month follow-up (4.070.8 to 5.070.7 Â 10 4 mU/(ml min), P ¼ 0.12). There was no effect of the procedure on beta-cell responsiveness as measured by the AIRg. There was a 30% increase in glucose effectiveness between baseline and 1-month follow-up (P ¼ 0.05) and a 47% increase in glucose effectiveness between the day after the liposuction and the 1-month follow-up (P ¼ 0.002). In order to examine the effect of baseline BMI on the change in insulin sensitivity, the effect of the change in insulin sensitivity overweight (BMI o30) vs obese (BMI430) was examined. At baseline there was a very good correlation between BMI and insulin sensitivity (R ¼ 0.872, Po0.001).
Following the procedure, the obese had a significant improvement in S I (2.2870.33 to 3.8970.89, P ¼ 0.03, n ¼ 8). The overweight had no significant change in their S I following the procedure (6.4871.23 to 6.5871.09, P ¼ 0.93). There were several parameters related to cardiovascular risk that worsened acutely around the time of the liposuction including IL-6 which increased 15-fold immediately following liposuction and was still 14-fold higher the day following liposuction (Table 3) . Similarly, angiotensin II increased 67% immediately following liposuction and was still elevated by 28% the day after the liposuction (Table 3) . This did not appear to be due to simple destruction of adipose tissue as there was no change in PAI-1, and other adipokines including adiponectin, leptin, and TNF-a, all decreased significantly immediately after and the day following the liposuction. Interestingly, triglycerides decreased significantly around the time of the liposuction. At the 1-month follow-up, all parameters were similar to levels seen at baseline (Table 3) . There was no difference in changes in adipokines or insulin sensitivity when the data were analyzed after the exclusion of the one participant who did not receive clonidine.
Discussion
This is the first study to examine the effect of small-volume suction lipectomy on insulin sensitivity, inflammatory mediators, and other cardiovascular risk factors. Additionally, this is the first study to carefully characterize the acute effects of liposuction on insulin sensitivity and inflammatory mediators. These results are significant for several reasons. Even with small-volume liposuction, there was an acute worsening of several inflammatory markers. By 1 month all factors had returned to baseline. There was an also an improvement in insulin sensitivity as measured by fasting parameters at 1 month. Although there was no significant change overall in insulin sensitivity by FSIVGTT, there was a significant increase in insulin sensitivity in the obese participants, and there was an increase in glucose effectiveness in the entire group at the 1-month follow-up.
The insulin sensitivity tended to worsen the day following liposuction with fasting glucose increasing, and a 25% decrease in S I and 17% decrease in Sg (both nonsignificant). Insulin levels significantly decreased the day following liposuction, but there was no significant change in FFAs or other measures of insulin sensitivity (HOMA, QUICKI, AIRg). One potential confounding factor impacting the acute change in insulin levels is catecholamine levels. Systemic catecholamines increase with liposuction both due to the stress of the procedure as well as the infusion of epinephrine with the liposuction infusate. Although it has been reported that epinephrine levels return to close to normal by the next day, 26 it cannot be definitively ruled out that the acute decrease in insulin levels was attributed to this increase in catecholamine levels. 27 However, the slight decrease in FFAs rather than an increase would argue against systemic catecholamines having a profound effect. The lack of a surgical control group with a stress similar to this but not directly involving adipose tissue is an obvious limitation of this study. Comparing these results to a study which evaluated insulin sensitivity by FSIVGTT the day after hernioplasty in 11 lean young men, the hernioplasty procedure resulted in a significant 16% decrease in S I , a 32% decrease in Sg, and a 17% decrease in AIRg. 28 Thus, the acute changes in insulin sensitivity are commensurate with those seen with a similar surgical stress. The 1-month insulin sensitivity results are similar to several previous studies that have shown that large-volume liposuction improves insulin sensitivity as measured using either fasting parameters or an insulin tolerance test. 13 However, a recent study by Klein et al. using a staged hyperinsulinemic euglycemic clamp with tracer technology failed to find any difference in insulin sensitivity 10-12 weeks after abdominal liposuction despite approximately 10 kg of fat loss. 18 Reasons for this discrepancy include differences in time since the liposuction and the differences in what is measured by the method used to test insulin sensitivity. Gonzalez-Ortiz et al. 20 evaluated insulin sensitivity by insulin tolerance test at approximately 1 month In the present study, free fatty acid levels were decreased significantly 1 month following liposuction. It has been demonstrated that a decrease in free fatty acids can improve glucose effectiveness in both normal participants and individuals with type 2 diabetes. 30 Indeed, glucose effectiveness, which estimates glucose disposal independent of insulin, was the only parameter by FSIVGTT that increased significantly at 1 month following liposuction. Hypothetically, this could be related to the loss of adipose tissue with liposuction signaling the need for adipogenesis, and an increase in adipogenic factors that also increase acutely the glucose effectiveness. One such factor is PKC-x/l as it has been suggested that PKC-x might have a role in both adipogenesis and increased glucose effectiveness. 25 Further studies are needed to confirm that a difference in glucose effectiveness is indeed present, and to determine the time course for these changes. The acute effect seen on IL-6, adiponectin, and angiotensin II has not been previously described. Consistent with the trend for worsening insulin sensitivity immediately following liposuction, IL-6 and angiotensin II increased significantly, whereas adiponectin decreased. It is unlikely this was due to cellular damage as previous studies have shown little damage to adipocytes with liposuction without the supplemental use of ultrasound. 31 Additionally, in this study other adipose tissue factors did not increase, and in fact adiponectin and leptin both decreased immediately following the procedure. Others have also reported an acute decrease in leptin following liposuction. 32 It is likely that part of the acute decrease in leptin seen was due to the downregulation of leptin by the infused epinephrine, as we and others have shown that catecholamines decrease leptin. 33 As there was no group who underwent a similar surgical intervention that did not directly involve adipose tissue, the effect of the surgical stress itself as a cause for the increased IL-6 and angiotensin II and decrease in leptin versus and adipose tissue-specific effect cannot be excluded.
The longer-term (3-6 months) effects of liposuction on mediators of inflammation is controversial. Klein et al. 18 did not see any effect at B3 months on adiponectin, TNF-a, IL-6, or C-reactive protein, whereas Giugliano et al. 17 found significant decreases TNF-a, IL-6, and C-reactive protein, and they found a significant increase in adiponectin.
Although the confounding effect of liposuction volume cannot be eliminated, our study is similar to the study by Klein et al. 18 in that there was no significant change in any of these inflammatory mediators at 1 month in this protocol. Other large-volume liposuction studies have shown a longerterm decrease in leptin. 18, 32 However, with the lesser amount of adipose tissue removed, and the change in total body fat of o1% in this small-volume study (compared to a 46% decrease in fat in one large-volume liposuction study 18 ) we did not observe a significant decrease in leptin.
In summary, although fasting parameters relating to insulin sensitivity improved at 1 month following suction lipectomy, a formal measure of insulin sensitivity by FSIVGTT showed no improvement. Despite acute changes in several adipose tissue hormones immediately following liposuction, these hormones returned to baseline at 1 month. Given the worsening of these adipokines acutely, small-volume liposuction might be associated with increased cardiovascular risk in the days following the procedure. However, by 1 month there does not appear to be either an improvement or an increase in cardiovascular risk based on these parameters.
